Delisting Determination,The Nasdaq Stock Market, LLC,
July 28, 2009, Oscient Pharmaceuticals Corporation. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Oscient Pharmaceuticals
Corporation (the Company), effective at the opening of the
trading session on August 7, 2009. Based on a review of
the information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for
listing on the Exchange pursuant to Listing Rules
5210(d), 5100, 5110(b) and IM-5100-1. The Company was
notified of the Staffs determinations on July 10, 2009 and
July 14, 2009. The Company did not appeal the Staff
determinations to the Hearings Panel, and the Staff
determination to delist the Company became final on
July 21, 2009.